Phenomics Health Acquires Precera Pharmacometabolomic Technology

Nov 22, 2019

|

NEW YORK — Bioinformatics firm Phenomics Health said today that it has acquired the pharmacometabolomic technology portfolio of Precera Bioscience.

Terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

European Regulators Begin Review of Sputnik V

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Irish Funding Agency Seeks Boost

Science reports that Science Foundation Ireland is seeking annual budget increases.

Lower Fees Sought

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

Nature Papers Examine Peregrine Falcon Migration Patterns, Tool to Search Single-Cell Data

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.

Featured White Papers

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

From Synthetic Gene to Vaccine: Confidence with GeneArt Gene Synthesis Services A GenomeWeb eCase Study Transcript

Harnessing the Power of the Expi Protein Expression Systems in Vaccine Development A GenomeWeb eCase Study Transcript

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX NGS DNA Hotspot 21 Kit

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Mar

23

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Mar

29

Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Menu

Phenomics Health Acquires Precera Pharmacometabolomic Technology

To read the full story....

Breaking News

C2i Genomics Acquires Sequencing Lab QNA Dx

Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix

Waters Enters $500M Senior Notes Private Placement

Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

Agilent Prices $850M Senior Notes Offering

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

The Scan

European Regulators Begin Review of Sputnik V

Irish Funding Agency Seeks Boost

Lower Fees Sought

Nature Papers Examine Peregrine Falcon Migration Patterns, Tool to Search Single-Cell Data

Featured White Papers

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

What's Popular?

Human Pangenome Reference Consortium Releases Data From 30 Genomes

Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

GenomSys Banks on MPEG-G Standard to Make Genome Analysis Mobile

Genomics plc Closes $30M Funding Round

Sponsorships